Synchronous Hodgkin Lymphoma and Papillary Thyroid Carcinoma: The Importance of Positron Emission Tomography/Computed Tomography (PET/CT)
Burak Uz 1 *
More Detail
1 Adult Hematology Clinic, Medicana International Samsun Hospital, Samsun, Turkey
* Corresponding Author

Abstract

We report a 50-year-old male with synchronous Hodgkin lymphoma (HL) and papillary thyroid carcinoma (PTC). The patient was diagnosed as having HL of the nodular sclerosis type on excisional biopsy of an enlarged right scalene node in March 2018. After further examinations including bone marrow biopsy and positron emission tomography/computed tomography (PET/CT) with 2-[18F]-fluoro-2-deoxy-D-glucose (18F-FDG), he was classified as having stage IVA HL with bone marrow involvement. The patient’s medical history was unremarkable for any chronic disease or previous throid disease. He had no history of irradiation to head and neck, nor had any regular medications. Her mother had a diagnosis of breast carcinoma.

License

This is an open access article distributed under the Creative Commons Attribution License (CC BY 4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Letter to Editor

https://doi.org/10.5799/jcei/5761

J Clin Exp Invest, 2019 - Volume 10 Issue 1, Article No: em00722

Publication date: 03 May 2019

Article Views: 782

Article Downloads: 594

Open Access References How to cite this article